| Accession number;00A0499847 |
| Title;Blood circulation and cancer. |
| Author;KA K(Sensaishochuidai) |
Journal Title;Eastern Medicine
|
Journal Code:L0095A
|
ISSN:0911-7768
|
|
VOL.16;NO.1;PAGE.45-49(2000)
|
| Figure&Table&Reference;REF.34 |
| Pub. Country;Japan |
| Language;Japanese |
| Abstract;In the case of cancer, the system of "blood coagulation-fibrinolysis-platelet" is confused and becomes a state of "high-congelation" and "low-fibrinolysis". The blood platelet is activated and a fibrin or a thrombus occurs in a blood vessel distributed in the cancer tissue. The blood condition of cancer patient like this is considered as a stagnant blood on the Chinese medicine. The stagnant blood becomes one of the conditions of cancer metastasis by promoting formation of cancer cell embolus. The formation of the cancer cell embolus is a cause that cancer cells aren't destroyed in immunity system, on the other hand, cancer cells get weak sensitively on the amputation-action of blood flow than any other blood cells, and so to protect a normal condition of blood flow is needed for the prevention and the treatment of cancer metastasis. Elimination the stagnant and activating the blood is a traditional way to treat cancer on the Chinese medicine. In the blood circulation promoting medicine, Salvia miltiorrhiza Bunge (Tansan) restrains DNA composition of cancer cells and leads apoptosis of cancer cells, and the polysaccharide of Carthamus tinctorius L. has an action to control immunity promoting the change of T-lymph cells. (author abst.) |
